Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel.

de Kruijff IE, Sieuwerts AM, Onstenk W, Kraan J, Smid M, Van MN, van der Vlugt-Daane M, Hoop EO, Mathijssen RHJ, Lolkema MP, de Wit R, Hamberg P, Meulenbeld HJ, Beeker A, Creemers GJ, Martens JWM, Sleijfer S.

Cancers (Basel). 2019 Aug 20;11(8). pii: E1212. doi: 10.3390/cancers11081212.

PMID:
31434336
2.

Maternity Care for Pregnant Women with Opioid Use Disorder: A Review.

Rizk AH, Simonsen SE, Roberts L, Swanson LT, Lemoine JB, Smid M.

J Midwifery Womens Health. 2019 Aug 12. doi: 10.1111/jmwh.13019. [Epub ahead of print] Review.

PMID:
31407485
3.

Downregulation of matrix Gla protein is a biomarker for tamoxifen-resistant and radioresistant breast cancer.

Post AE, Bussink J, Smid M, Sweep FC, Span PN.

Biomark Med. 2019 Jul;13(10):841-850. doi: 10.2217/bmm-2019-0050. Epub 2019 Jul 18.

PMID:
31317787
4.

Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes.

Koedoot E, Fokkelman M, Rogkoti VM, Smid M, van de Sandt I, de Bont H, Pont C, Klip JE, Wink S, Timmermans MA, Wiemer EAC, Stoilov P, Foekens JA, Le Dévédec SE, Martens JWM, van de Water B.

Nat Commun. 2019 Jul 5;10(1):2983. doi: 10.1038/s41467-019-11020-3.

5.

A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy.

McLaughlin RP, He J, van der Noord VE, Redel J, Foekens JA, Martens JWM, Smid M, Zhang Y, van de Water B.

Breast Cancer Res. 2019 Jul 1;21(1):77. doi: 10.1186/s13058-019-1161-9.

6.

Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAs.

Amirnasr A, Gits CMM, van Kuijk PF, Smid M, Vriends ALM, Rutkowski P, Sciot R, Schöffski P, Debiec-Rychter M, Sleijfer S, Wiemer EAC.

Cancers (Basel). 2019 Jun 24;11(6). pii: E882. doi: 10.3390/cancers11060882.

7.

Social Accountability in Maternal Health Services in the Far-Western Development Region in Nepal: An Exploratory Study.

Hamal M, Heiter K, Schoenmakers L, Smid M, de Cock Buning T, De Brouwere V, Bardají A, Nepal C, Dieleman M.

Int J Health Policy Manag. 2019 Feb 17;8(5):280-291. doi: 10.15171/ijhpm.2019.05.

8.

Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths.

Smid MC, Stone NM, Baksh L, Debbink MP, Einerson BD, Varner MW, Gordon AJ, Clark EAS.

Obstet Gynecol. 2019 Jun;133(6):1131-1140. doi: 10.1097/AOG.0000000000003279.

PMID:
31135726
9.

Intergenerational transmission of emotion dysregulation: Part I. Psychopathology, self-injury, and parasympathetic responsivity among pregnant women.

Lin B, Kaliush PR, Conradt E, Terrell S, Neff D, Allen AK, Smid MC, Monk C, Crowell SE.

Dev Psychopathol. 2019 Aug;31(3):817-831. doi: 10.1017/S0954579419000336. Epub 2019 May 8.

PMID:
31064587
10.

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.

Uhr K, Prager-van der Smissen WJC, Heine AAJ, Ozturk B, van Jaarsveld MTM, Boersma AWM, Jager A, Wiemer EAC, Smid M, Foekens JA, Martens JWM.

PLoS One. 2019 May 7;14(5):e0216400. doi: 10.1371/journal.pone.0216400. eCollection 2019.

11.

Correction: Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects.

Meijer TG, Verkaik NS, Sieuwerts AM, van Riet J, Naipal KAT, van Deurzen CHM, den Bakker MA, Sleddens HFBM, Dubbink HJ, den Toom TD, Dinjens WNM, Lips E, Nederlof PM, Smid M, van de Werken HJG, Kanaar R, Martens JWM, Jager A, van Gent DC.

Clin Cancer Res. 2019 May 1;25(9):2935. doi: 10.1158/1078-0432.CCR-19-0936. No abstract available.

PMID:
31043383
12.

Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation.

Brinkman AB, Nik-Zainal S, Simmer F, Rodríguez-González FG, Smid M, Alexandrov LB, Butler A, Martin S, Davies H, Glodzik D, Zou X, Ramakrishna M, Staaf J, Ringnér M, Sieuwerts A, Ferrari A, Morganella S, Fleischer T, Kristensen V, Gut M, van de Vijver MJ, Børresen-Dale AL, Richardson AL, Thomas G, Gut IG, Martens JWM, Foekens JA, Stratton MR, Stunnenberg HG.

Nat Commun. 2019 Apr 15;10(1):1749. doi: 10.1038/s41467-019-09828-0.

13.

Co-regulated gene expression of splicing factors as drivers of cancer progression.

Koedoot E, Smid M, Foekens JA, Martens JWM, Le Dévédec SE, van de Water B.

Sci Rep. 2019 Apr 2;9(1):5484. doi: 10.1038/s41598-019-40759-4.

14.

Laser-wakefield accelerators for high-resolution X-ray imaging of complex microstructures.

Hussein AE, Senabulya N, Ma Y, Streeter MJV, Kettle B, Dann SJD, Albert F, Bourgeois N, Cipiccia S, Cole JM, Finlay O, Gerstmayr E, González IG, Higginbotham A, Jaroszynski DA, Falk K, Krushelnick K, Lemos N, Lopes NC, Lumsdon C, Lundh O, Mangles SPD, Najmudin Z, Rajeev PP, Schlepütz CM, Shahzad M, Smid M, Spesyvtsev R, Symes DR, Vieux G, Willingale L, Wood JC, Shahani AJ, Thomas AGR.

Sci Rep. 2019 Mar 1;9(1):3249. doi: 10.1038/s41598-019-39845-4.

15.

Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.

de Kruijff IE, Sieuwerts AM, Onstenk W, Jager A, Hamberg P, de Jongh FE, Smid M, Kraan J, Timmermans MA, Martens JWM, Sleijfer S.

Int J Cancer. 2019 Aug 15;145(4):1083-1089. doi: 10.1002/ijc.32209. Epub 2019 Feb 27.

PMID:
30761532
16.

The circular RNome of primary breast cancer.

Smid M, Wilting SM, Uhr K, Rodríguez-González FG, de Weerd V, Prager-Van der Smissen WJC, van der Vlugt-Daane M, van Galen A, Nik-Zainal S, Butler A, Martin S, Davies HR, Staaf J, van de Vijver MJ, Richardson AL, MacGrogan G, Salgado R, van den Eynden GGGM, Purdie CA, Thompson AM, Caldas C, Span PN, Sweep FCGJ, Simpson PT, Lakhani SR, Van Laere S, Desmedt C, Paradiso A, Eyfjord J, Broeks A, Vincent-Salomon A, Futreal AP, Knappskog S, King T, Viari A, Børresen-Dale AL, Stunnenberg HG, Stratton M, Foekens JA, Sieuwerts AM, Martens JWM.

Genome Res. 2019 Mar;29(3):356-366. doi: 10.1101/gr.238121.118. Epub 2019 Jan 28.

PMID:
30692147
17.

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GKJ, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, Van't Veer L, Tutt A, Knappskog S, Tan BKT, Jonkers J, Borg Å, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JWM, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR.

Nature. 2019 Feb;566(7742):E1. doi: 10.1038/s41586-019-0883-2.

PMID:
30659290
18.

Half a degree and rapid socioeconomic development matter for heatwave risk.

Russo S, Sillmann J, Sippel S, Barcikowska MJ, Ghisetti C, Smid M, O'Neill B.

Nat Commun. 2019 Jan 11;10(1):136. doi: 10.1038/s41467-018-08070-4.

19.

Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.

Smid MC, Metz TD, Gordon AJ.

Clin Obstet Gynecol. 2019 Mar;62(1):168-184. doi: 10.1097/GRF.0000000000000418. Review.

PMID:
30601144
20.

Mitochondrial RNA Expression and Single Nucleotide Variants in Association with Clinical Parameters in Primary Breast Cancers.

Weerts MJA, Smid M, Foekens JA, Sleijfer S, Martens JWM.

Cancers (Basel). 2018 Dec 9;10(12). pii: E500. doi: 10.3390/cancers10120500.

21.

Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.

Timbergen MJM, Janssen ML, Verhoef C, Grünhagen DJ, Chibon F, Smid M, Sleijfer S, Wiemer EAC.

Eur J Surg Oncol. 2019 Apr;45(4):691-698. doi: 10.1016/j.ejso.2018.09.019. Epub 2018 Oct 18.

PMID:
30528042
22.

Maternal Pre-Pregnancy Obesity Attenuates Response to Omega-3 Fatty Acids Supplementation During Pregnancy.

Monthé-Drèze C, Penfield-Cyr A, Smid MC, Sen S.

Nutrients. 2018 Dec 4;10(12). pii: E1908. doi: 10.3390/nu10121908.

23.

Child Neurodevelopmental Outcomes by Prepregnancy Body Mass Index and Gestational Weight Gain.

Kominiarek MA, Smid MC, Mele L, Casey BM, Sorokin Y, Reddy UM, Wapner RJ, Thorp JM Jr, Saade GR, Tita ATN, Rouse DJ, Sibai B, Iams JD, Mercer BM, Tolosa J, Caritis SN; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU).

Obstet Gynecol. 2018 Dec;132(6):1386-1393. doi: 10.1097/AOG.0000000000002974.

PMID:
30399108
24.

Factors Associated with Previable Delivery following Second Trimester Rupture of Membranes.

Panzer A, Dotters-Katz S, Smid M, Boggess K, Manuck T.

Am J Perinatol. 2019 Jul;36(8):812-817. doi: 10.1055/s-0038-1675373. Epub 2018 Nov 2.

PMID:
30388716
25.

The Effect of Blood Loss on Cefazolin Levels in Women Undergoing Cesarean Delivery.

Dotters-Katz SK, Smid MC, Grace MR, Gunatilake RP, Sykes C, Blake K, Boggess KA, Patil AS, Manuck T.

Am J Perinatol. 2019 Jun;36(7):688-694. doi: 10.1055/s-0038-1673654. Epub 2018 Oct 18.

PMID:
30336498
26.

Maternal BMI, Mid-pregnancy Fatty Acid Concentrations,and Perinatal Outcomes.

Penfield-Cyr A, Monthe-Dreze C, Smid MC, Sen S.

Clin Ther. 2018 Oct;40(10):1659-1667.e1. doi: 10.1016/j.clinthera.2018.08.011. Epub 2018 Sep 19.

PMID:
30241686
27.

Use of Kratom, an Opioid-like Traditional Herb, in Pregnancy.

Smid MC, Charles JE, Gordon AJ, Wright TE.

Obstet Gynecol. 2018 Oct;132(4):926-928. doi: 10.1097/AOG.0000000000002871.

PMID:
30204686
28.

Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.

Lagendijk M, Saadatmand S, Koppert LB, Tilanus-Linthorst MMA, de Weerd V, Ramírez-Moreno R, Smid M, Sieuwerts AM, Martens JWM.

Oncotarget. 2018 Aug 10;9(62):32096. doi: 10.18632/oncotarget.25979. eCollection 2018 Aug 10.

29.

Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects.

Meijer TG, Verkaik NS, Sieuwerts AM, van Riet J, Naipal KAT, van Deurzen CHM, den Bakker MA, Sleddens HFBM, Dubbink HJ, den Toom TD, Dinjens WNM, Lips E, Nederlof PM, Smid M, van de Werken HJG, Kanaar R, Martens JWM, Jager A, van Gent DC.

Clin Cancer Res. 2018 Dec 15;24(24):6277-6287. doi: 10.1158/1078-0432.CCR-18-0063. Epub 2018 Aug 23. Erratum in: Clin Cancer Res. 2019 May 1;25(9):2935.

PMID:
30139880
30.

The Use of a Game-Based Decision Aid to Educate Pregnant Women about Prenatal Screening: A Randomized Controlled Study.

Rothwell E, Johnson E, Wong B, Rose NC, Latendresse G, Altizer R, Zagal J, Smid M, Watson A, Botkin JR.

Am J Perinatol. 2019 Feb;36(3):322-328. doi: 10.1055/s-0038-1667371. Epub 2018 Aug 14.

31.

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.

Uhr K, Sieuwerts AM, de Weerd V, Smid M, Hammerl D, Foekens JA, Martens JWM.

Sci Rep. 2018 Jun 25;8(1):9657. doi: 10.1038/s41598-018-27987-w.

32.

Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons.

Smid M, Coebergh van den Braak RRJ, van de Werken HJG, van Riet J, van Galen A, de Weerd V, van der Vlugt-Daane M, Bril SI, Lalmahomed ZS, Kloosterman WP, Wilting SM, Foekens JA, IJzermans JNM; MATCH study group, Martens JWM, Sieuwerts AM.

BMC Bioinformatics. 2018 Jun 22;19(1):236. doi: 10.1186/s12859-018-2246-7.

33.

Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression.

Kolijn K, Verhoef EI, Smid M, Böttcher R, Jenster GW, Debets R, van Leenders GJLH.

Cancer Res. 2018 Aug 15;78(16):4671-4679. doi: 10.1158/0008-5472.CAN-17-3752. Epub 2018 Jun 19.

34.

MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.

Lagendijk M, Sadaatmand S, Koppert LB, Tilanus-Linthorst MMA, de Weerd V, Ramírez-Moreno R, Smid M, Sieuwerts AM, Martens JWM.

Oncotarget. 2018 May 11;9(36):24335-24346. doi: 10.18632/oncotarget.25262. eCollection 2018 May 11. Erratum in: Oncotarget. 2018 Aug 10;9(62):32096.

35.

The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome.

de Kruijff IE, Timmermans AM, den Bakker MA, Trapman-Jansen AMAC, Foekens R, Meijer-Van Gelder ME, Oomen-de Hoop E, Smid M, Hollestelle A, van Deurzen CHM, Foekens JA, Martens JWM, Sleijfer S.

Cancers (Basel). 2018 May 5;10(5). pii: E134. doi: 10.3390/cancers10050134.

36.

Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer.

Post AEM, Smid M, Nagelkerke A, Martens JWM, Bussink J, Sweep FCGJ, Span PN.

Clin Cancer Res. 2018 Jul 15;24(14):3397-3408. doi: 10.1158/1078-0432.CCR-17-2551. Epub 2018 Apr 16.

37.

Preclinical Labor-and-Delivery Shadowing: The Impact on Medical Students' Perceptions of Obstetrics and Gynecology.

Dotters-Katz S, Panzer A, Givens M, Smid M, Chuang A.

AJP Rep. 2018 Apr;8(2):e64-e67. doi: 10.1055/s-0038-1641723. Epub 2018 Apr 11.

38.

Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice.

Li F, Kakoki M, Smid M, Boggess K, Wilder J, Hiller S, Bounajim C, Parnell SE, Sulik KK, Smithies O, Maeda-Smithies N.

Hypertension. 2018 May;71(5):894-903. doi: 10.1161/HYPERTENSIONAHA.117.10849. Epub 2018 Apr 2.

39.

Confirmation of a metastasis-specific microRNA signature in primary colon cancer.

Coebergh van den Braak RRJ, Sieuwerts AM, Lalmahomed ZS, Smid M, Wilting SM, Bril SI, Xiang S, van der Vlugt-Daane M, de Weerd V, van Galen A, Biermann K, van Krieken JHJM, Kloosterman WP, Foekens JA; MATCH study group*, Martens JWM, IJzermans JNM.

Sci Rep. 2018 Mar 27;8(1):5242. doi: 10.1038/s41598-018-22532-1.

40.

Maternal obesity, fish intake, and recurrent spontaneous preterm birth.

Smid MC, Stuebe AM, Manuck TA, Sen S.

J Matern Fetal Neonatal Med. 2019 Aug;32(15):2486-2492. doi: 10.1080/14767058.2018.1439008. Epub 2018 Feb 21.

PMID:
29415593
41.

Measurement of Preheat Due to Nonlocal Electron Transport in Warm Dense Matter.

Falk K, Holec M, Fontes CJ, Fryer CL, Greeff CW, Johns HM, Montgomery DS, Schmidt DW, Šmíd M.

Phys Rev Lett. 2018 Jan 12;120(2):025002. doi: 10.1103/PhysRevLett.120.025002.

PMID:
29376698
42.

T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.

Mustafa DAM, Pedrosa RMSM, Smid M, van der Weiden M, de Weerd V, Nigg AL, Berrevoets C, Zeneyedpour L, Priego N, Valiente M, Luider TM, Debets R, Martens JWM, Foekens JA, Sieuwerts AM, Kros JM.

Acta Neuropathol. 2018 Apr;135(4):581-599. doi: 10.1007/s00401-018-1806-2. Epub 2018 Jan 19.

43.

Use of prophylactic antibiotics in women with previable prelabor rupture of membranes.

Dotters-Katz SK, Myrick O, Smid M, Manuck TA, Boggess KA, Goodnight W.

J Neonatal Perinatal Med. 2017;10(4):431-437. doi: 10.3233/NPM-16165.

PMID:
29286934
45.

Breast cancer genomics and immuno-oncological markers to guide immune therapies.

Hammerl D, Smid M, Timmermans AM, Sleijfer S, Martens JWM, Debets R.

Semin Cancer Biol. 2018 Oct;52(Pt 2):178-188. doi: 10.1016/j.semcancer.2017.11.003. Epub 2017 Nov 6. Review.

46.

Corrigendum: A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers.

Glodzik D, Morganella S, Davies H, Simpson PT, Li Y, Zou X, Diez-Perez J, Staaf J, Alexandrov LB, Smid M, Brinkman AB, Rye IH, Russnes H, Raine K, Purdie CA, Lakhani SR, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JWM, Børresen-Dale AL, Richardson AL, Kong G, Viari A, Easton D, Evan G, Campbell PJ, Stratton MR, Nik-Zainal S.

Nat Genet. 2017 Oct 27;49(11):1661. doi: 10.1038/ng1117-1661a.

PMID:
29074948
47.

Prophylactic Negative Pressure Wound Therapy for Obese Women After Cesarean Delivery: A Systematic Review and Meta-analysis.

Smid MC, Dotters-Katz SK, Grace M, Wright ST, Villers MS, Hardy-Fairbanks A, Stamilio DM.

Obstet Gynecol. 2017 Nov;130(5):969-978. doi: 10.1097/AOG.0000000000002259. Review.

PMID:
29016508
48.

High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.

Coebergh van den Braak RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, Bril SI, van Galen A, Smid M, Biermann K, van Krieken JHJM, Kloosterman WP, Foekens JA, Goel A, Martens JWM, IJzermans JNM; MATCH study group.

PLoS One. 2017 Sep 28;12(9):e0185607. doi: 10.1371/journal.pone.0185607. eCollection 2017.

49.

Perioperative Antibiotic Choice in Labored versus Unlabored Cesareans and Risk of Postcesarean Infectious Morbidity.

Hopkins MK, Dotters-Katz S, Boggess K, Heine RP, Smid M.

Am J Perinatol. 2018 Jan;35(2):127-133. doi: 10.1055/s-0037-1606187. Epub 2017 Aug 24.

PMID:
28838006
50.

Body Mass Index 50 kg/m2 and Beyond: Perioperative Care of Pregnant Women With Superobesity Undergoing Cesarean Delivery.

Smid MC, Dotters-Katz SK, Silver RM, Kuller JA.

Obstet Gynecol Surv. 2017 Aug;72(8):500-510. doi: 10.1097/OGX.0000000000000469. Review.

PMID:
28817167

Supplemental Content

Support Center